208 related articles for article (PubMed ID: 33998710)
1. Successful treatment of congenital systemic juvenile xanthogranulomatosis with pulmonary involvement.
Ataseven E; Kizmazoglu D; Oniz H
Pediatr Dermatol; 2021 Jul; 38(4):892-894. PubMed ID: 33998710
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy.
Nakatani T; Morimoto A; Kato R; Tokuda S; Sugimoto T; Tokiwa K; Tsuchihashi Y; Imashuku S
J Pediatr Hematol Oncol; 2004 Jun; 26(6):371-4. PubMed ID: 15167350
[TBL] [Abstract][Full Text] [Related]
3. Juvenile Xanthogranuloma: An Entity With a Wide Clinical Spectrum.
Hernández-San Martín MJ; Vargas-Mora P; Aranibar L
Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):725-733. PubMed ID: 32721389
[TBL] [Abstract][Full Text] [Related]
4. Treatment of juvenile xanthogranuloma.
Stover DG; Alapati S; Regueira O; Turner C; Whitlock JA
Pediatr Blood Cancer; 2008 Jul; 51(1):130-3. PubMed ID: 18338395
[TBL] [Abstract][Full Text] [Related]
5. Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma.
McClain KL
Clin Perinatol; 2021 Mar; 48(1):167-179. PubMed ID: 33583503
[TBL] [Abstract][Full Text] [Related]
6. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
[TBL] [Abstract][Full Text] [Related]
7. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of systemic juvenile xanthogranulomatosis with cytarabine and 2-chlorodeoxyadenosine: case report and review of the literature.
Maintz L; Wenzel J; Irnich M; Reinhard H; Bieber T
Br J Dermatol; 2017 Feb; 176(2):481-487. PubMed ID: 27312940
[TBL] [Abstract][Full Text] [Related]
9. Juvenile xanthogranuloma as a sequel to Langerhans cell histiocytosis: a report of three cases.
Hoeger PH; Diaz C; Malone M; Pritchard J; Harper JI
Clin Exp Dermatol; 2001 Jul; 26(5):391-4. PubMed ID: 11488823
[TBL] [Abstract][Full Text] [Related]
10. [Juvenile xanthogranuloma: 3 cases report and literature review].
Liu ZQ; Liu R; Shi XD; Li JX; Zou JZ
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):614-7. PubMed ID: 22338156
[TBL] [Abstract][Full Text] [Related]
11. Deep juvenile xanthogranuloma: an unusual presentation.
Neveling U; Kahn LB; Valderrama E; Poustchi-Amin M; Uckan D; Shende A
Pediatr Pathol Lab Med; 1997; 17(3):503-11. PubMed ID: 9185228
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cell histiocytosis and juvenile xanthogranuloma. Two case reports.
Patrizi A; Neri I; Bianchi F; Guerrini V; Misciali C; Paone G; Burnelli R
Dermatology; 2004; 209(1):57-61. PubMed ID: 15237270
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cell histiocytosis preceding the development of juvenile xanthogranuloma: a case and review of recent developments.
Bains A; Parham DM
Pediatr Dev Pathol; 2011; 14(6):480-4. PubMed ID: 21793710
[TBL] [Abstract][Full Text] [Related]
14. Fine-needle cytology of cutaneous juvenile xanthogranuloma and langerhans cell histiocytosis.
Fassina A; Olivotto A; Cappellesso R; Vendraminelli R; Fassan M
Cancer Cytopathol; 2011 Apr; 119(2):134-40. PubMed ID: 21491610
[TBL] [Abstract][Full Text] [Related]
15. Is disseminated juvenile xanthogranulomatosis benign cephalic histiocytosis?
Sidwell RU; Francis N; Slater DN; Mayou SC
Pediatr Dermatol; 2005; 22(1):40-3. PubMed ID: 15660896
[TBL] [Abstract][Full Text] [Related]
16. Disseminated juvenile xanthogranuloma occurring after treatment of Langerhans cell histiocytosis: a case report.
Lee TK; Jung TY; Baek HJ; Kim SK; Lee KH; Yun SJ
Childs Nerv Syst; 2018 Apr; 34(4):765-770. PubMed ID: 29209883
[TBL] [Abstract][Full Text] [Related]
17. An 'eruptive' variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis.
Tran DT; Wolgamot GM; Olerud J; Hurst S; Argenyi Z
J Cutan Pathol; 2008 Oct; 35 Suppl 1():50-4. PubMed ID: 18840155
[TBL] [Abstract][Full Text] [Related]
18. A rare case of neonatal systemic xanthogranulomatosis with severe hepatic disease and metachronous skin involvement.
Papadakis V; Volonaki E; Katsibardi K; Stefanaki K; Valari M; Anagnostakou M; Polychronopoulou S
J Pediatr Hematol Oncol; 2012 Apr; 34(3):226-8. PubMed ID: 22031119
[TBL] [Abstract][Full Text] [Related]
19. Langerhans Cell Histiocytosis Evolving into Juvenile Xanthogranuloma: Two Linked Entities.
Shaker N; Sangueza OP
Am J Dermatopathol; 2023 Apr; 45(4):259-263. PubMed ID: 36801831
[TBL] [Abstract][Full Text] [Related]
20. Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma.
Mavi ME; Turan BS; Salanci BV; Bozkurt MF
Clin Nucl Med; 2022 May; 47(5):e395-e396. PubMed ID: 35085175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
